Skip to content

Study · Not a test of the peptide alone · 1990

1 result

Limited proteolysis of the vasoactive intestinal peptide receptor: comparison of its folded structure in the membrane-bound and detergent-solubilized states.

Provow SA, Veliçelebi G

Regulatory peptides1 Mar 1990Cited by 2 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone1

In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

  1. 01LabNot a test of Vasoactive intestinal peptide (VIP, aviptadil) aloneIn vitro (cell-free)Activity measurement

    In rat lung preparations, VIP receptors extracted with digitonin kept the ability to bind 125I-VIP, while those solubilized in Triton X-100 showed little or no activity.

    In plain wordsIn lab tests, rat lung VIP receptors kept binding VIP after extraction with digitonin but not after extraction with Triton X-100.

    Outcome
    Not applicable125I-VIP binding of detergent-solubilized receptors
    Study

    ratn: not reported in source

    rat lung VIP receptor, membrane-bound and detergent-solubilized
    Outcome group
    Receptor activity and mechanism · Pharmacology

    Source sentences

    Summary
    Receptors that were extracted from the membrane using digitonin retained the ability to bind 125I-VIP, while those solubilized in Triton X-100 displayed little or no detectable activity.
    1 context sentence
    Summary · context
    Limited proteolysis was used to probe and compare the conformation of the rat lung vasoactive intestinal peptide (VIP) receptor in membrane-bound and detergent-solubilized states.

    In this study, Vasoactive intestinal peptide (VIP, aviptadil) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Vasoactive intestinal peptide (VIP, aviptadil).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    12 Oct 2026, 12:58 UTC

    Study results updated

  2. Version 1

    9 Oct 2026, 12:41 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.